ISSN: 1744-1331

Journal Guideline

Health Economics, Policy and Law Q1 Unclaimed

Cambridge University Press United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Health Economics, Policy and Law is a journal indexed in SJR in Health Policy with an H index of 44. It has a price of 1626,56 €. It has an SJR impact factor of 1,001 and it has a best quartile of Q1. It has an SJR impact factor of 1,001.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Health Policy (Q1)

Price

1626,56 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,001

SJR Impact factor

44

H Index

39

Total Docs (Last Year)

104

Total Docs (3 years)

880

Total Refs

309

Total Cites (3 years)

103

Citable Docs (3 years)

3.13

Cites/Doc (2 years)

22.56

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Planetary Health Q1
Health Affairs Q1
Alzheimer's and Dementia Q1
Implementation Science Q1
Milbank Quarterly Q1

Compare this journals

Aims and Scope

Best articles by citations

Opening the black box of diagnosis-related groups (DRGs): unpacking the technical remuneration structure of the Dutch DRG system

Coping accountably in a dangerous world

Addressing perceived economic obstacles to genetic testing as a way to mitigate disparities in family health history for adoptees

Specialization and physician-ownership in the US hospital industry: beyond the moratorium

Response to our critics

The political economy of Chinese health reform

The role of EU competition law in health care and the 'undertaking' concept

Peering through a glass: darkly

Taking the iron fist a little further

Understanding recent increases in chronic disease treatment rates: more disease or more detection?

America's health care dilemma: not a pretty sight

Information will be the key to successful implementation

SHOW MORE ARTICLES

The introduction of a targeted user-pays approach to funding high-level residential aged care in Australia: an empirical investigation of the impact on price

Coverage mandates and market dynamics: employer, insurer and patient responses to parity laws

Health economics made easy: guiding the initiated and uninitiated

Health economics methods for public health resource allocation: a qualitative interview study of decision makers from an English local authority

Financial impact of the GFC: health care spending across the OECD

Value congruence in health care priority setting: social values, institutions and decisions in three countries

Does managed competition constrain hospitals' contract prices? Evidence from the Netherlands

The implementation of European Union (EU) rules on cross-border care: moving towards convergence?

Visible hand or invisible fist?: the new market and choice in the English NHS

Political party ambitions and type-2 diabetes policy in Brazil and Mexico

Personal responsibility in the NHS Constitution and the social determinants of health approach: competitive or complementary?

Politics over economics, fist over hand